中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
26期
85-86
,共2页
丙戊酸钠%脑卒中后癫痫%临床疗效
丙戊痠鈉%腦卒中後癲癇%臨床療效
병무산납%뇌졸중후전간%림상료효
Sodium valproate%Post-stroke epilepsy%Clinical efficacy
目的：探讨丙戊酸钠治疗脑卒中后癫痫的临床效果。方法选取2011年6月~2013年6月本院收治的50例脑卒中后癫痫患者，按照随机数字表法分为对照组和实验组各25例，对照组给予抗凝、改善脑血液循环治疗，实验组在对照组治疗的基础上给予丙戊酸钠治疗，比较两组的临床疗效。结果治疗后，实验组癫痫发作率为16.0%，低于对照组的36.0%，差异有统计学意义(P<0.05)。两组神经功能缺损程度比较，差异有统计学意义(P<0.05)。结论丙戊酸钠治疗脑卒中后癫痫，效果显著，具有较高的临床价值，值得在各级医院推广应用。
目的：探討丙戊痠鈉治療腦卒中後癲癇的臨床效果。方法選取2011年6月~2013年6月本院收治的50例腦卒中後癲癇患者，按照隨機數字錶法分為對照組和實驗組各25例，對照組給予抗凝、改善腦血液循環治療，實驗組在對照組治療的基礎上給予丙戊痠鈉治療，比較兩組的臨床療效。結果治療後，實驗組癲癇髮作率為16.0%，低于對照組的36.0%，差異有統計學意義(P<0.05)。兩組神經功能缺損程度比較，差異有統計學意義(P<0.05)。結論丙戊痠鈉治療腦卒中後癲癇，效果顯著，具有較高的臨床價值，值得在各級醫院推廣應用。
목적：탐토병무산납치료뇌졸중후전간적림상효과。방법선취2011년6월~2013년6월본원수치적50례뇌졸중후전간환자，안조수궤수자표법분위대조조화실험조각25례，대조조급여항응、개선뇌혈액순배치료，실험조재대조조치료적기출상급여병무산납치료，비교량조적림상료효。결과치료후，실험조전간발작솔위16.0%，저우대조조적36.0%，차이유통계학의의(P<0.05)。량조신경공능결손정도비교，차이유통계학의의(P<0.05)。결론병무산납치료뇌졸중후전간，효과현저，구유교고적림상개치，치득재각급의원추엄응용。
Objective To analyze the clinical efficacy of sodium valproate for treatment of post-stroke epilepsy. Meth-ods 50 patients with post-stroke epilepsy from June 2011 to June 2013 were selected and divided into experimental group and control group according to the random number table.The control group were given with treatment with the objective of anticoagulation and improving cerebral blood circulation while the experimental group were given with ad-ditional sodium valproate on the basis of control group.The clinical effect was observed. Results After treatment,the epileptic attack rate was 16.0%in the experimental group,lower than 36.0% in the control group,the difference was sig-nificant (P<0.05);the neural function deficiency between two groups had statistical difference (P<0.05). Conclusion Sodium valproate has better clinical efficacy for post-stroke epilepsy,has high clinical value,which is worthy of promo-tion in hospitals of different levels.
